Federated Investors Inc. PA raised its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 9.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 407,565 shares of the pharmacy operator’s stock after acquiring an additional 36,773 shares during the period. Federated Investors Inc. PA’s holdings in Walgreens Boots Alliance were worth $31,917,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently bought and sold shares of WBA. Reilly Financial Advisors LLC boosted its position in shares of Walgreens Boots Alliance by 7.9% in the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after buying an additional 100 shares during the period. Orrstown Financial Services Inc. boosted its position in shares of Walgreens Boots Alliance by 14.1% in the second quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after buying an additional 213 shares during the period. Private Vista LLC boosted its position in shares of Walgreens Boots Alliance by 6,403.7% in the second quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock worth $140,000 after buying an additional 574,218 shares during the period. Founders Capital Management purchased a new stake in shares of Walgreens Boots Alliance in the first quarter worth about $161,000. Finally, Modera Wealth Management LLC boosted its position in shares of Walgreens Boots Alliance by 0.4% in the first quarter. Modera Wealth Management LLC now owns 2,451 shares of the pharmacy operator’s stock worth $204,000 after buying an additional 9 shares during the period. 60.19% of the stock is owned by hedge funds and other institutional investors.
Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded down 3.92% during midday trading on Friday, hitting $64.48. The stock had a trading volume of 21,902,851 shares. The company has a market cap of $69.00 billion, a P/E ratio of 16.28 and a beta of 1.25. The stock’s 50-day moving average is $75.41 and its 200-day moving average is $79.78. Walgreens Boots Alliance, Inc. has a one year low of $63.82 and a one year high of $89.69.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.21 by $0.10. The business had revenue of $30.15 billion for the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The firm’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same quarter last year, the business posted $1.07 EPS. Equities analysts predict that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.48%. The ex-dividend date of this dividend is Friday, November 10th. Walgreens Boots Alliance’s payout ratio is 42.33%.
Walgreens Boots Alliance declared that its board has initiated a stock buyback plan on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to reacquire shares of its stock through open market purchases. Shares buyback plans are typically a sign that the company’s board believes its shares are undervalued.
TRADEMARK VIOLATION WARNING: “Federated Investors Inc. PA Has $31.92 Million Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2017/10/28/federated-investors-inc-pa-has-31-92-million-holdings-in-walgreens-boots-alliance-inc-wba.html.
Several research firms recently commented on WBA. Needham & Company LLC reiterated a “buy” rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a research note on Thursday, October 12th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Thursday, October 5th. BidaskClub cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. Leerink Swann set a $86.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Friday, July 7th. Finally, Credit Suisse Group restated a “buy” rating and set a $97.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, July 13th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and fifteen have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $88.11.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.